What athagoras Group does

athagoras Group is a Munich-based holding company (athagoras Holding GmbH, founded 2024) that operates a roll-up platform of specialized life sciences consulting firms. The company acquires and partners with boutique consultancies serving pharmaceutical, biotech, and medtech clients across Europe and the US, preserving each firm's brand and leadership while layering on shared infrastructure and cross-sell capabilities. Service delivery is organized around five pillars: Regulatory Affairs, Pharmacovigilance, Market Access, Real World Evidence (RWE), and Technology/Data & AI. As of early 2026, the platform aggregates nine firms — MIGx, RCH Solutions, S-cubed, IGES group, Quantify Research, CSO-Pharma, DiaMed, confinis ag, and Ecker + Ecker (with Accessus Health) — giving the group operational presence in Germany, the UK, Switzerland, Sweden, France, Italy, Spain, and the US.

The underlying technology stack combines data and AI services (data mesh, data fabric, knowledge graphs, machine learning, AI-enabled systematic/living literature reviews), security services (penetration testing, intrusion detection, identity management), infrastructure/cloud (multi-hybrid, IaC, monitoring), and integration services (DevOps, API management, robotic process automation). Quantify Research provides a differentiated data asset: Nordic real-world data covering over 150 million patient-years, used by 19 of the top 20 global pharmaceutical companies. athagoras is an EMA ENCePP partner, qualifying the group to deliver GVP-compliant Post-Authorization Safety Studies (PASS) and Efficacy Studies (PAES).

The business model is professional services consulting, sold directly to enterprise pharmaceutical, biotech, and medtech customers. The company is sales-led out of Munich headquarters with no disclosed pricing or contracted revenue figures. Across subsidiaries, individual customer bases range from 100+ active clients (confinis ag) to concentrated enterprise relationships with top-20 global pharma (Quantify Research) and major medtech manufacturers. Revenue is generated through bespoke consulting engagements; no software licensing, SaaS subscriptions, or transaction-based pricing is disclosed. The group is privately held with no public financial filings, and no external private equity sponsor is publicly named — though Greenpeak Partners has publicly supported strategic transactions.

Name

athagoras Group

Legal name

athagoras Holding GmbH

Website

https://athagoras.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

51–100 employees

Short description

athagoras Group is a Munich-based holding company that operates a roll-up platform of nine specialized life sciences consulting firms, delivering regulatory affairs, pharmacovigilance, market access, real-world evidence, and data/AI services to pharmaceutical, biotech, and medtech clients across Europe and the US.

Ownership category

akta.pro rank

Product category

Life Sciences Consulting Services

NAICS

Management Consulting Services (54161), Other Management Consulting Services (541618), Custom Computer Programming Services (541511)

SIC

Services-Management Consulting Services (8742), Services-Computer Programming Services (7371)

akta.pro primary industry

Data, Analytics & AI Consulting (BPAHACAI)

akta.pro secondary industries

Data, Analytics & AI Consulting (BPAHAEAF), Emerging Tech (IoT, Blockchain, AR/VR, Edge) Consulting (BPAHAEAL)

Keywords

• Life sciences consulting
• Regulatory affairs services
• Pharmacovigilance consulting
• Market access solutions
• Real-world evidence analytics

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Professional Consulting Services: athagoras provides specialized consulting services to pharmaceutical, biotech, and medtech companies in regulatory affairs, pharmacovigilance, market access, real-world evidence, and technology. Revenue is generated through professional services engagements.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

athagoras is a life sciences platform that brings together specialized consulting firms to deliver integrated services for pharmaceutical, biotech, and medtech clients across Regulatory Affairs, Pharmacovigilance, Market Access, Real World Evidence, and Technology/Data & AI. The platform combines deep domain consulting with tech-enabled solutions such as AI, data integration, security, and cloud infrastructure. Services are delivered through nine wholly-owned subsidiary firms maintaining distinct brands across Europe and the US.

Product overview

athagoras is a life sciences platform that brings together specialized consulting firms to advance next-generation therapies. The platform operates through five core service pillars: Regulatory Affairs (regulatory strategy, end-to-end approval support, post-approval compliance), Pharmacovigilance (PV systems, screening, reporting, roles, PASS/PAES studies), Market Access (strategy, HTA/value dossiers, health economic modelling, pricing, negotiations, health systems), Real World Evidence (study design and execution, evidence synthesis, AI-enabled analysis), and Technology/Data & AI (data strategy, AI/machine learning, security, cloud infrastructure, integration services). The platform aggregates 9 acquired specialist firms: MIGx and RCH Solutions (technology), S-cubed and DiaMed (regulatory affairs), Quantify Research and IGES (RWE and market access), CSO-Pharma and DiaMed (pharmacovigilance), confinis ag (MedTech regulatory), and Ecker + Ecker (market access/JCA), creating an integrated European service provider for the pharmaceutical, biotech, and medtech industries.

Differentiator

Problem solved

Functional benefit

Products and services

• Regulatory Affairs Comprehensive regulatory affairs consulting covering regulatory strategy, intelligence and advice, end-to-end support through regulatory approval processes, and post-approval support including variations, renewals, and compliance maintenance, provided to pharmaceutical and biotech clients.
• Pharmacovigilance End-to-end pharmacovigilance services including PV systems (PSMF, SOPs, contracts, quality assurance, training, audit), PV screening (case reports, signal detection, literature search, ADR monitoring, legislation screening), PV reporting (RMPs, aggregate reports), PV roles (QPPV, LSO), and safety studies (PASS, PAES) for pharmaceutical clients.
• Market Access Market access services including market access strategy and recommendations, HTA and value dossier development, health economic modelling (cost-effectiveness, budget impact, value tools), pricing and negotiations support, European launch management, and health systems analysis for pharmaceutical clients.
• Real World Evidence Real-world evidence solutions including RWE study design and execution (cohort studies, pragmatic trials, registries), evidence review and synthesis (biostatistics, systematic/living reviews, network meta-analysis, indirect treatment comparisons), AI-enabled data visualization, literature review and evidence synthesis, and medical writing and editorial support for pharmaceutical and biotech clients.
• Technology / Data & AI Technology services including data and AI services (data strategy, governance, data mesh, data fabric, business intelligence, knowledge graphs, machine learning), security services (security strategy, penetration testing, identity management, data security, intrusion detection, vulnerability management), infrastructure and cloud (multi-hybrid cloud, infrastructure as code, IAM, monitoring), and integration services (app development, digital strategy, API management, DevOps, RPA) for life sciences clients.
• Health Systems Analysis of European health systems including national healthcare infrastructures, reimbursement mechanisms, policy environments, and stakeholder mapping for strategic alignment and optimized access strategies for pharmaceutical clients.

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature4 records

Partnerships

Ten partnerships are on record, tiered core.

• Ecker + EckercoreStrategic or Co-development Partner · 1 April 2026athagoras announced in April 2026 that Ecker + Ecker GmbH is joining the Group, marking a decisive step toward a leading position in Joint Clinical Assessments (JCA). Ecker + Ecker is a leading German consultancy in Market Access with deep expertise in AMNOG (German HTA), pricing and reimbursement, and a network of 250+ local experts.
• Accessus HealthcoreStrategic or Co-development Partner · 1 April 2026athagoras announced in April 2026 that Accessus Health GmbH is joining the Group alongside Ecker + Ecker, establishing athagoras as a partner of choice for multinational Market Access.
• DiaMedcoreStrategic or Co-development Partner · 1 October 2025athagoras acquired DiaMed Beratungsgesellschaft in October 2025 to strengthen Regulatory Affairs and Pharmacovigilance expertise. Founded in 1992 by Dr. Johannes Kremer, DiaMed is a well-established German consultancy specializing in RA and PV with decades of hands-on experience.
• confinis agcoreStrategic or Co-development Partner · 1 October 2025athagoras acquired confinis ag in October 2025 to strengthen regulatory capabilities. Headquartered in Düdingen, Switzerland, confinis is a tech-enabled consulting firm specializing in regulatory affairs, quality assurance, and compliance solutions for MedTech and pharmaceutical clients across Europe and North America. Founded in 2005 with 100+ active clients.
• IGES GroupcoreStrategic or Co-development Partner · 1 March 2025The IGES Group joined the athagoras group in March 2025 to drive forward internationalization and expertise in the healthcare sector. IGES is a network of research and consulting companies in Europe specializing in healthcare, with companies in six EU member countries and the UK. IGES Pharma offers end-to-end launch support for pharma and medtech with over 40 years of experience and 200+ experts.
• S-cubedcoreStrategic or Co-development Partner · 1 January 2025S-cubed Ltd is a regulatory affairs and quality assurance consultancy company, providing services to clients from around the world from their UK based offices. Founded in 2008, the company brings a wealth of experience and expertise to the athagoras group. S-cubed Biometrics Ltd continues to operate independently.
• Quantify ResearchcoreStrategic or Co-development Partner · 1 January 2025athagoras acquired Quantify Research in January 2025 to enhance real-world evidence and market access capabilities. Quantify is a Nordic-headquartered specialist in RWE and market access, serving 19 of the top 20 global pharmaceutical companies. Founded in 2011, the company leverages Nordic real-world data covering over 150 million patient-years.
• MIGxcoreStrategic or Co-development Partner · 1 November 2024MIGx is a Life Sciences focused technology consulting and engineering company. They leverage deep expertise across research and development domains to deliver tailored data, AI, security and cloud services to Life Sciences clients. Greenpeak Partners supported the strategic collaboration between athagoras and MIGx to enhance tech-enabled services for the pharma and biotech sectors.
• RCH SolutionscoreStrategic or Co-development Partner · 1 November 2024RCH Solutions is a specialist in providing data management, cloud solutions and AI services exclusively to life science companies in the US. Part of the athagoras group portfolio.
• CSO-PharmacoreStrategic or Co-development Partner · 1 November 2024CSO Pharma Consulting GmbH joined the athagoras group in November 2024 to enlarge and internationalize pharmacovigilance and development services for the pharma and healthcare sectors. CSO Pharma provides pharmacovigilance, medical affairs, quality management and GDP consulting services.

Scale indicators6 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Health Advances: Health Advances is a mid-sized strategy consulting firm focused exclusively on life sciences, advising pharma, biotech, medtech and diagnostics on commercial strategy, market access and product development — directly overlapping athagoras's strategy and market access pillars.
• Clearview Healthcare Partners: Clearview Healthcare Partners is a life sciences-focused strategy consulting firm serving pharma and biotech across commercial, R&D and medical affairs. Closely comparable to athagoras in customer base and the strategic-advisory slice of its offerings.
• Putnam Associates: Putnam Associates is a pharma and biotech strategy consulting firm specializing in commercial strategy, pricing, market access and launch excellence — directly comparable to athagoras's Market Access and RWE services.
• Alcimed: Alcimed is a European-headquartered innovation and consulting firm with a dedicated life sciences practice covering pharma, biotech and medtech. Directly comparable in European market focus and life sciences advisory positioning.
• PharmaLex (Cencora): PharmaLex (now part of Cencora) is a leading global regulatory affairs, pharmacovigilance and market access consultancy serving pharma, biotech and medtech. Directly comparable to athagoras's regulatory/PV/MA service lines and similarly built via serial acquisitions.
• Charles River Associates (CRA): CRA's Life Sciences practice provides management and economic consulting to pharma and biotech across litigation, regulatory, pricing and market access. Comparable in consulting depth and EU/US footprint to athagoras's market access and HTA work.

Broad incumbents

• IQVIA: IQVIA is the largest global CRO and life sciences data/consulting provider, offering regulatory, RWE, market access and technology services. Overlaps with athagoras across nearly all service lines but at vastly greater scale.
• ZS Associates: ZS Associates is a large global consulting firm with deep pharma and biotech practices in commercial strategy, market access, real-world evidence and analytics. Overlaps with athagoras on data-driven market access and RWE but operates at significantly larger scale.
• ICON plc: ICON is a leading global CRO offering clinical, regulatory, bioanalytical and consulting services to pharma and biotech. Overlaps with athagoras on regulatory and clinical-adjacent consulting but as part of a much broader full-service CRO portfolio.
• Parexel: Parexel is a major global CRO with substantial regulatory affairs, market access, RWE and biopharmaceutical consulting capabilities. Comparable service breadth to athagoras but operates at significantly larger scale with global delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/athagoras

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about athagoras Group